{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:39:09Z","timestamp":1788255549089,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/22\/M\/NZ3\/00679 (BK)"],"award-info":[{"award-number":["2016\/22\/M\/NZ3\/00679 (BK)"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Human RECQL4 and BLM helicases participate in all DNA dependent processes, including replication stress, DNA damage repair. Both helicases are overexpressed in glioblastoma (GBM), a lethal primary brain tumour, characterised by resistance to radio- and chemotherapy. BLM-depleted glioma cells exhibit senescence-associated or polypoid phenotype when exposed to temozolomide (TMZ) and olaparib (OLA), a PARP inhibitor. This study aims to investigate how RECQL4 depletion influences the response of malignant gliomas to chemotherapeutics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We investigated the effect of RECQL4 depletion in glioma cells on cell growth, apoptosis, senescence and polyploidy in the response to combined TMZ and OLA treatment. We compared transcriptomes of RECQL4- and BLM-depleted LN18 and LN229 glioma cells. Drug-induced cytotoxicity, senescence-associated phenotypes, cell cycle alterations, and polyploidy were assessed using the MTT metabolic assay, \u03b2-galactosidase activity assay, and propidium iodide staining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>RECQL4 depletion modestly affected basal glioma cell viability and proliferation, similarly to knock out of the BLM protein. Deletion of RECQL4 in glioma cells (RQ4 KO) induced profound transcriptomic alterations, dissimilar to BLM depletion. RECQL4-depleted glioma cells treated with TMZ and OLA exhibited reduced viability and increased levels of apoptosis markers. The treatment induced cell cycle arrest, however, RQ4 KO cells did not show signs of senescence phenotype or polyploidisation, when compared to BLM KO glioma cells. Interestingly, both RQ4 KO and BLM KO cells were more resistant to WP744, a doxorubicin derivative, when compared to WT LN229 glioma cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results highlight the distinct roles of RecQ helicases in a response to chemotherapeutics and support a rationale for targeting RECQL4 as a therapeutic strategy in glioblastoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14932-0","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:10:58Z","timestamp":1759144258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Shared and non-overlapping functions of RECQL4 and BLM helicases in chemotherapeutics-induced glioma cell responses"],"prefix":"10.1186","volume":"25","author":[{"given":"Kamil","family":"Wojnicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Wojtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona A.","family":"Ciechomska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Kaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Guille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Priebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozena","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"14932_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0959-437X(99)00039-8","volume":"10","author":"JK Karow","year":"2000","unstructured":"Karow JK, Wu L, Hickson ID. RecQ family helicases: roles in cancer and aging. Curr Opin Genet Dev. 2000;10:32\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"14932_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrc1012","volume":"3","author":"ID Hickson","year":"2003","unstructured":"Hickson ID. Recq helicases: caretakers of the genome. Nat Rev Cancer. 2003;3:169\u201378.","journal-title":"Nat Rev Cancer"},{"key":"14932_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/MCB.00613-10","volume":"31","author":"T Katsunori","year":"2011","unstructured":"Katsunori T, Ryota I, Tatsuya K, Hiroyuki S, Yukiko M, Naoki K, et al. Fission yeast Pot1 and recq helicase are required for efficient chromosome segregation. Mol Cell Biol. 2011;31:495\u2013506.","journal-title":"Mol Cell Biol"},{"key":"14932_CR4","doi-asserted-by":"publisher","first-page":"e201800120","DOI":"10.26508\/lsa.201800120","volume":"2","author":"H Yokoyama","year":"2019","unstructured":"Yokoyama H, Moreno-Andres D, Astrinidis SA, Hao Y, Weberruss M, Schellhaus AK, et al. Chromosome alignment maintenance requires the MAP RECQL4, mutated in the Rothmund\u2013thomson syndrome. Life Sci Alliance. 2019;2:e201800120.","journal-title":"Life Sci Alliance"},{"key":"14932_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2020.106433","volume":"265","author":"A Mojumdar","year":"2020","unstructured":"Mojumdar A. Mutations in conserved functional domains of human recq helicases are associated with diseases and cancer: a review. Biophys Chem. 2020;265:106433.","journal-title":"Biophys Chem"},{"key":"14932_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147301","author":"B Abu-Libdeh","year":"2022","unstructured":"Abu-Libdeh B, Jhujh SS, Dhar S, Sommers JA, Datta A, Longo GMC, et al. Recon syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI147301.","journal-title":"J Clin Invest"},{"key":"14932_CR7","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1242\/jcs.02556","volume":"118","author":"M Petkovic","year":"2005","unstructured":"Petkovic M, Dietschy T, Freire R, Jiao R, Stagljar I. The human Rothmund-Thomson syndrome gene product, RECQL4, localizes to distinct nuclear foci that coincide with proteins involved in the maintenance of genome stability. J Cell Sci. 2005;118:4261\u20139.","journal-title":"J Cell Sci"},{"key":"14932_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.10.021","volume":"413","author":"D Mo","year":"2018","unstructured":"Mo D, Zhao Y, Balajee AS. Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells. Cancer Lett. 2018;413:1\u201310.","journal-title":"Cancer Lett"},{"key":"14932_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al. The epidemiology of glioma in adults: a state of the science review. Neuro-Oncol. 2014;16:896\u2013913.","journal-title":"Neuro-Oncol"},{"key":"14932_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11060-017-2685-4","volume":"136","author":"E Audureau","year":"2018","unstructured":"Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, et al. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol. 2018;136:565\u201376.","journal-title":"J Neurooncol"},{"key":"14932_CR11","first-page":"12","volume":"8","author":"B Fulton","year":"2017","unstructured":"Fulton B, Short SC, James A, Nowicki S, McBain C, Jefferies S, et al. PARADIGM-2: two parallel phase I studies of Olaparib and radiotherapy or Olaparib and radiotherapy plus Temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status. Clin Transl Radiat Oncol. 2017;8:12\u20136.","journal-title":"Clin Transl Radiat Oncol"},{"key":"14932_CR12","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1158\/1078-0432.CCR-19-2000","volume":"26","author":"F Higuchi","year":"2020","unstructured":"Higuchi F, Nagashima H, Ning J, Koerner MVA, Wakimoto H, Cahill DP. Restoration of Temozolomide sensitivity by PARP inhibitors in mismatch repair deficient glioblastoma is independent of base excision repair. Clin Cancer Res. 2020;26:1690\u20139.","journal-title":"Clin Cancer Res"},{"key":"14932_CR13","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/neuonc\/noaa104","volume":"22","author":"C Hanna","year":"2020","unstructured":"Hanna C, Kurian KM, Williams K, Watts C, Jackson A, Carruthers R, et al. Pharmacokinetics, safety, and tolerability of Olaparib and Temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro Oncol. 2020;22:1840\u201350.","journal-title":"Neuro Oncol"},{"key":"14932_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102919","author":"SK Kr\u00f3l","year":"2020","unstructured":"Kr\u00f3l SK, Kaczmarczyk A, Wojnicki K, Wojtas B, Gielniewski B, Grajkowska W, et al. Aberrantly expressed recql4 helicase supports proliferation and drug resistance of human glioma cells and glioma stem cells. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12102919.","journal-title":"Cancers (Basel)"},{"key":"14932_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41420-023-01451-9","volume":"9","author":"K Wojnicki","year":"2023","unstructured":"Wojnicki K, Kaczmarczyk A, Wojtas B, Kaminska B. BLM helicase overexpressed in human gliomas contributes to diverse responses of human glioma cells to chemotherapy. Cell Death Discov. 2023;9:157.","journal-title":"Cell Death Discov"},{"key":"14932_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jss.2004.03.027","volume":"121","author":"TH Inge","year":"2004","unstructured":"Inge TH, Harris NL, Wu J, Azizkhan RG, Priebe W. WP744 is a novel anthracycline with enhanced activity against neuroblastoma1. J Surg Res. 2004;121:187\u201396.","journal-title":"J Surg Res"},{"key":"14932_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"14932_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47:e47\u201347.","journal-title":"Nucleic Acids Res"},{"key":"14932_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"14932_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178:835\u2013e84921.","journal-title":"Cell"},{"key":"14932_CR21","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/onc.2012.174","volume":"32","author":"IA Ciechomska","year":"2013","unstructured":"Ciechomska IA, Gabrusiewicz K, Szczepankiewicz AA, Kaminska B. Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine A-induced cell death. Oncogene. 2013;32:1518\u201329.","journal-title":"Oncogene"},{"key":"14932_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pits.20234","volume":"44","author":"B Thompson","year":"2007","unstructured":"Thompson B. Effect sizes, confidence intervals, and confidence intervals for effect sizes. Psychol Sch. 2007;44:423\u201332.","journal-title":"Psychol Sch"},{"key":"14932_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863.","journal-title":"Front Psychol"},{"key":"14932_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","volume":"5","author":"BY Lee","year":"2006","unstructured":"Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 2006;5:187\u201395.","journal-title":"Aging Cell"},{"key":"14932_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10637-006-9018-3","volume":"25","author":"TA Brooks","year":"2007","unstructured":"Brooks TA, O\u2019Loughlin KL, Minderman H, Bundy BN, Ford LA, Vredenburg MR, et al. The 4\u2032-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells. Invest New Drugs. 2007;25:115\u201322.","journal-title":"Invest New Drugs"},{"key":"14932_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jss.2004.05.017","volume":"122","author":"J Wu","year":"2004","unstructured":"Wu J, Harris NL, Inge TH. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. J Surg Res. 2004;122:231\u20139.","journal-title":"J Surg Res"},{"key":"14932_CR27","doi-asserted-by":"publisher","first-page":"e1005160","DOI":"10.1371\/journal.pgen.1005160","volume":"11","author":"AJM Ng","year":"2015","unstructured":"Ng AJM, Walia MK, Smeets MF, Mutsaers AJ, Sims NA, Purton LE, et al. The DNA helicase Recql4 is required for normal osteoblast expansion and osteosarcoma formation. PLoS Genet. 2015;11:e1005160.","journal-title":"PLoS Genet"},{"key":"14932_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102146","volume":"50","author":"W Huo","year":"2024","unstructured":"Huo W, Huang Y, Tian B, Chen X, Lu J, Huang X, et al. Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K\/AKT pathway. Transl Oncol. 2024;50:102146.","journal-title":"Transl Oncol"},{"key":"14932_CR29","doi-asserted-by":"publisher","first-page":"3685817","DOI":"10.1155\/2019\/3685817","volume":"2019","author":"K Chen","year":"2019","unstructured":"Chen K, Xu H, Zhao J. Bloom syndrome protein activates AKT and PRAS40 in prostate cancer cells. Oxid Med Cell Longev. 2019;2019:3685817.","journal-title":"Oxid Med Cell Longev"},{"key":"14932_CR30","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1242\/jcs.181297","volume":"129","author":"J Kumari","year":"2016","unstructured":"Kumari J, Hussain M, De S, Chandra S, Modi P, Tikoo S, et al. Mitochondrial functions of RECQL4 are required for the prevention of aerobic glycolysis-dependent cell invasion. J Cell Sci. 2016;129:1312\u20138.","journal-title":"J Cell Sci"},{"key":"14932_CR31","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1093\/nar\/gkp244","volume":"37","author":"J Atkinson","year":"2009","unstructured":"Atkinson J, McGlynn P. Replication fork reversal and the maintenance of genome stability. Nucleic Acids Res. 2009;37:3475\u201392.","journal-title":"Nucleic Acids Res"},{"key":"14932_CR32","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355:1152\u20138.","journal-title":"Science"},{"key":"14932_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12885-019-5413-y","volume":"19","author":"P Lesueur","year":"2019","unstructured":"Lesueur P, Lequesne J, Grellard J-M, Dugu\u00e9 A, Coquan E, Brachet P-E, et al. Phase i\/iia study of concomitant radiotherapy with Olaparib and Temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol. BMC Cancer. 2019;19:198.","journal-title":"BMC Cancer"},{"key":"14932_CR34","doi-asserted-by":"crossref","unstructured":"Gielniewski B, Poleszak K, Roura A-J, Szadkowska P, Krol SK, Guzik R, et al. The novel, recurrent mutation in the TOP2A gene results in the enhanced topoisomerase activity and transcription deregulation in glioblastoma. Int J Cancer. 2023;153:1003\u201315.","DOI":"10.1002\/ijc.34631"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14932-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:03:17Z","timestamp":1759183397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14932-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14932"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14932-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1434"}}